GlyProVac ApS

GlyProVac ApS (CVR number: 39724758) is a company from ODENSE. The company recorded a gross profit of -814.7 kDKK in 2022. The operating profit was -3119.2 kDKK, while net earnings were -2871.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -60.7 %, which can be considered poor and Return on Equity (ROE) was -124.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 15.4 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. GlyProVac ApS's liquidity measured by quick ratio was 11.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.